CRYSTALLINE FORMS OF PHTHALAZINONE COMPOUND

The present specification provides crystalline forms of 4-[3-(3-[(cyclopropylamino)methyl]azetidine-1-carbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one hydrochloride, methods of preparing the same, and pharmaceutical compositions comprising the same.

Saved in:
Bibliographic Details
Main Authors RYU, Keuncheol, YOON, Jinyoung, LEE, Kunhee, YANG, Hyeran, LEE, Seoktaek, SEO, Hanna, SEONG, Wonje
Format Patent
LanguageEnglish
Published 24.11.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present specification provides crystalline forms of 4-[3-(3-[(cyclopropylamino)methyl]azetidine-1-carbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one hydrochloride, methods of preparing the same, and pharmaceutical compositions comprising the same.
Bibliography:Application Number: US202217830756